Canton Strategic Holdings (CNTN) Liabilities and Shareholders Equity (2020 - 2026)

Canton Strategic Holdings (CNTN) posted Liabilities and Shareholders Equity of $584.7 million for Q1 2026, up 12.62% on a QoQ basis from $519.1 million in Q4 2025, and up 35092.72% year-over-year from N/an in Q1 2025.

Canton Strategic Holdings (CNTN) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

Canton Strategic Holdings' Liabilities and Shareholders Equity history runs 7 years deep, the most recent figure standing at $584.7 million for Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 35092.72% year-over-year to $584.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 5796.96% YoY) and the FY2025 annual result came in at $519.1 million, up 13849.46% from the prior year.
  • Liabilities and Shareholders Equity was $584.7 million for Q1 2026 at Canton Strategic Holdings, up from $519.1 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $584.7 million in Q1 2026 and bottomed at $1.7 million in Q1 2025.
  • A 5-year average of $70.7 million and a median of $7.7 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2025 — Liabilities and Shareholders Equity tumbled 81.31% — and 2026, when it soared 35092.72%.
  • Canton Strategic Holdings' Liabilities and Shareholders Equity stood at $6.7 million in 2022, then jumped by 63.66% to $10.9 million in 2023, then slumped by 66.0% to $3.7 million in 2024, then soared by 13849.46% to $519.1 million in 2025, then grew by 12.62% to $584.7 million in 2026.
  • Business Quant data shows CNTN's Liabilities and Shareholders Equity at $584.7 million in Q1 2026, $519.1 million in Q4 2025, and $7.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 311.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 78.88 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 8.55 Bn
4 NuCana 279.75 Bn 279.75 Bn - 39.68 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 26.48 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 40.87 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 811.27 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 10.03 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.25 Bn
10 Canton Strategic Holdings 427.87 Mn 427.87 Mn - 584.65 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 584.65 Mn
Dec 31, 2025 519.15 Mn
Sep 30, 2025 7.70 Mn
Jun 30, 2025 2.53 Mn
Mar 31, 2025 1.66 Mn
Dec 31, 2024 3.72 Mn
Sep 30, 2024 5.25 Mn
Jun 30, 2024 8.26 Mn
Mar 31, 2024 8.89 Mn
Dec 31, 2023 10.95 Mn
Sep 30, 2023 3.17 Mn
Jun 30, 2023 4.60 Mn
Mar 31, 2023 4.72 Mn
Dec 31, 2022 6.69 Mn
Sep 30, 2022 8.02 Mn
Jun 30, 2022 10.25 Mn
Mar 31, 2022 12.09 Mn
Dec 31, 2021 621,677.00
Dec 31, 2020 294,798.00